Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Provision of Aseptically Prepared Drugs to East and North Hertfordshire (ENHT) NHS Trust, including

  • First published: 16 May 2018
  • Last modified: 16 May 2018
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Hertfordshire NHS Procurement
Authority ID:
AA29661
Publication date:
16 May 2018
Deadline date:
11 June 2018
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

To meet the current and forecast service level requirements of the Contracting sites and wider region, it is expected that the successful Bidder will commit to building a new compounding facility in the Hertfordshire/Essex area to be operational within two years of award date and capable of providing a range of aseptically prepared products including Parenteral Nutrition (PN), Out-patient parenteral antimicrobial therapy (OPAT), Chemotherapy, Biologics and Clinical Trials investigational drugs. However, alternative proposal from bidders are welcome and bidders are invited to demonstrate other models and solutions to meet our requirements.

Furthermore, nationally there is a shortage of aseptic capacity, a situation which has been highlighted and reviewed jointly with NHS England and other stakeholders. The successful Bidder must meet the strategic need of the Trusts to increase the available aseptic capacity through investment in incremental production capability.

The successful Bidder must be able to accommodate the chemotherapy requirement of Lister and MV from the start of the new contract without impact on contracted service levels. It should also have a plan to introduce PAH’s chemotherapy requirement and all sites aseptic preparations requirement by 31.12.2019, such that both The Lister and PAH can decommission their current in-house facilities to their own timetable.

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

Hertfordshire NHS Procurement

Gate House, Fretherne Rd

Welwyn Garden City

AL8 6NS

UK

Contact person: Mr Grant Thrussell

Telephone: +44 1707356162

E-mail: grant.thrussell@hertsprocurement.nhs.uk

NUTS: UKH23

Internet address(es)

Main address: http://www.hertsprocurement.nhs.uk/

Address of the buyer profile: http://www.hertsprocurement.nhs.uk/

I.3) Communication

Access to the procurement documents is restricted. Further information can be obtained at:

https://procontract.due-north.com


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://procontract.due-north.com


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Provision of Aseptically Prepared Drugs to East and North Hertfordshire (ENHT) NHS Trust, including The Lister Site and The Mount Vernon (MV) Site and The Princess Alexandra Hospital (PAH) NHS Trust

Reference number: DN340088

II.1.2) Main CPV code

85149000

 

II.1.3) Type of contract

Services

II.1.4) Short description

Lister (East and North Herts NHS Trust) and Princess Alexandra Hospital to work in partnership to rationalise the services from both aging units that require significant capital to continue to provide the standard and capacity to cope with the increasing demand of aseptically prepared doses. In addition the scope of the tender also includes the Mount Vernon site, whose chemotherapy is currently provided by a third party. Due to the lack of capital investment within the NHS, we are inviting tenders for the provision of aseptically prepared drugs to East and North Hertfordshire Trust and Princess Alexandra Hospital in working partnership.

II.1.5) Estimated total value

Value excluding VAT: 10 000 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS code:

UKH23

UKH35

II.2.4) Description of the procurement

To meet the current and forecast service level requirements of the Contracting sites and wider region, it is expected that the successful Bidder will commit to building a new compounding facility in the Hertfordshire/Essex area to be operational within two years of award date and capable of providing a range of aseptically prepared products including Parenteral Nutrition (PN), Out-patient parenteral antimicrobial therapy (OPAT), Chemotherapy, Biologics and Clinical Trials investigational drugs. However, alternative proposal from bidders are welcome and bidders are invited to demonstrate other models and solutions to meet our requirements.

Furthermore, nationally there is a shortage of aseptic capacity, a situation which has been highlighted and reviewed jointly with NHS England and other stakeholders. The successful Bidder must meet the strategic need of the Trusts to increase the available aseptic capacity through investment in incremental production capability.

The successful Bidder must be able to accommodate the chemotherapy requirement of Lister and MV from the start of the new contract without impact on contracted service levels. It should also have a plan to introduce PAH’s chemotherapy requirement and all sites aseptic preparations requirement by 31.12.2019, such that both The Lister and PAH can decommission their current in-house facilities to their own timetable.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/02/2019

End: 31/01/2029

This contract is subject to renewal: Yes

Description of renewals:

Extension of 1 + 1 year.

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.12) Information about electronic catalogues

Tenders must be presented in the form of electronic catalogues or include an electronic catalogue

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

III.2.3) Information about staff responsible for the performance of the contract

Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Restricted procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 11/06/2018

Local time: 12:00

IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates

Date: 11/05/2018

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.4) Procedures for review

VI.4.1) Review body

The High Court of Justice

The Strand

London

WC2A 2LL

UK

VI.5) Date of dispatch of this notice

11/05/2018

Coding

Commodity categories

ID Title Parent category
85149000 Pharmacy services Miscellaneous health services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
grant.thrussell@hertsprocurement.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.